FeetMe
7
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Markers of Disease Progression and Gait Within the Parkinsonian Population
Role: collaborator
Assessment of vGRF Measurement During Walking With Feetme® Insoles in Healthy Adults
Role: lead
A Randomised, Controlled, Open-Label, Multi-Centre Study to Evaluate the Efficacy of FeetMe® Home-Bases Rehabilitation Program in Comparison to Conventional Physiotherapy in Patients With Parkinson's Disease Using Connected Insoles
Role: lead
Identifying Risk Factors for Falls in Patients With a High Risk of Fracture Using Connected Insoles (FeetMe Monitor® Device)
Role: lead
VALIDITY AND RELIABILITY OF THE 6-MINUTES WALKING TEST EVALUATED BY FEETME® INSOLES
Role: lead
Validation Study : FeetMe® Monitor Insoles for the Evaluation of Gait Speed
Role: lead
FeetMe® Monitor: Alternative for the Evaluation of Gait Speed After Stroke
Role: lead
All 7 trials loaded